Mayfair Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$477K Sell
3,967
-314
-7% -$36.3K 0.17% 102
2025
Q4
$456K Sell
4,281
-2
-0% -$188 0.18% 101
2025
Q3
$359K Buy
4,283
+124
+3% +$10.2K 0.15% 117
2025
Q2
$336K Sell
4,159
-21
-0.5% -$1.67K 0.16% 119
2025
Q1
$375K Sell
4,180
-1,209
-22% -$113K 0.22% 92
2024
Q4
$536K Buy
5,389
+464
+9% +$47.8K 0.32% 62
2024
Q3
$541K Buy
4,925
+25
+0.5% +$2.97K 0.34% 54
2024
Q2
$626K Sell
4,900
-92
-2% -$11.9K 0.42% 45
2024
Q1
$659K Buy
4,992
+148
+3% +$18.2K 0.48% 41
2023
Q4
$549K Buy
4,844
+200
+4% +$20.8K 0.47% 42
2023
Q3
$481K Buy
4,644
+550
+13% +$59.3K 0.46% 48
2023
Q2
$446K Hold
4,094
0.45% 52
2023
Q1
$472K Hold
4,094
0.51% 48
2022
Q4
$452K Sell
4,094
-241
-6% -$24.6K 0.58% 47
2022
Q3
$380K Buy
4,335
+777
+22% +$69.4K 0.54% 50
2022
Q2
$318K Buy
3,558
+121
+4% +$10.7K 0.42% 71
2022
Q1
$287K Buy
3,437
+348
+11% +$27.4K 0.37% 65
2021
Q4
$244K Buy
3,089
+14
+0.5% +$1.11K 0.32% 80
2021
Q3
$256K Buy
3,075
+250
+9% +$19K 0.39% 70
2021
Q2
$220K Sell
2,825
-83
-3% -$6.17K 0.35% 83
2021
Q1
$214K Sell
2,908
-755
-21% -$55.7K 0.38% 80
2020
Q4
$286K Sell
3,663
-17
-0.5% -$1.3K 0.56% 49
2020
Q3
$291K Buy
3,680
+599
+19% +$46.9K 0.75% 34
2020
Q2
$227K Buy
+3,081
New +$232K 0.73% 37

Other funds holding MRK

Mayfair Advisory Group's MRK Position: Q1 2026 in Review

Mayfair Advisory Group reduced its Merck (MRK) stake by 7.3% in Q1 2026, selling an estimated $36.3K and leaving 3,967 shares worth $477K. The position accounts for 0.17% of the portfolio, ranked #102.

Mayfair Advisory Group first reported a position in MRK in Q2 2020 and has held it in 24 quarters since. The position peaked at $659K in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Mayfair Advisory Group held 3,967 shares of Merck worth $477K as of Q1 2026.
  • Mayfair Advisory Group sold 314 Merck shares in Q1 2026, an estimated $36.3K.
  • Merck made up 0.17% of Mayfair Advisory Group's portfolio in Q1 2026, its #102 holding.
  • Mayfair Advisory Group first reported a position in Merck in Q2 2020 and has held it in 24 quarters since.
  • Mayfair Advisory Group's Merck position peaked at $659K in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Mayfair Advisory Group's 13F filing for Q1 2026, filed 21 Apr 2026.